This is interesting I am called a down ramper most of the time. Yet my prediction are beater than these from UBS. From my post yesterday in the Range rover section of post Post #: 52416505 I Predicted they would have a yearly profit of 10 Cents to 15 cents and said how I came to it. UBS was at low end of my range at 10 cents..
I predicted revenue of 450M ~ 550 M they said 462M
I said a negative cash flow of 30 to 50 M Which would be a closing cash balance of 460 to 480 M They said closing balance of 362M. They call this debt not cash At end of year they say minus 99M Lynas says plus 101M So they are including some of the Debt in there number. I could not figure out exactly what they are including but JARE is 147M so that is allot of it. So they do have a lower cash burn than me we will have to wait till Q3 report to see which way it is going.
So why am I a down ramper? only reason I can think of is I keep asking where the profits come from to justify $6.00 SP in the next 1 to 2 years. Nobody seems to be able to answer. So since no one can show where profits come from why not just call me a down ramper. Insults are always easier than facts.
- Forums
- ASX - By Stock
- LYC
- Earnings...
Earnings..., page-19
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.35 |
Change
-0.050(0.78%) |
Mkt cap ! $5.935B |
Open | High | Low | Value | Volume |
$6.46 | $6.47 | $6.34 | $19.83M | 3.109M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11865 | $6.35 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.36 | 3637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 6.350 |
4 | 5536 | 6.340 |
4 | 13908 | 6.330 |
6 | 42312 | 6.320 |
6 | 24381 | 6.310 |
Price($) | Vol. | No. |
---|---|---|
6.370 | 3462 | 2 |
6.380 | 18088 | 2 |
6.390 | 11392 | 2 |
6.400 | 16874 | 4 |
6.420 | 785 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online